No Data
No Data
HC Wainwright & Co. Initiates Coverage On Structure Therapeutics With Buy Rating, Announces Price Target of $80
Structure Therapeutics Analyst Ratings
Why Is Structure Therapeutics Inc. (GPCR) Among the Best Up and Coming Stocks to Buy According to Analysts?
U.S. stock market anomaly | Weight loss drug concept stocks are generally up, Eli Lilly (LLY.US) up more than 4%.
On Tuesday, stocks related to weight loss drugs initially rose broadly, with eli lilly and co (LLY.US) up over 4%, scpharmaceuticals (GPCR.US) up over 2%, and novo-nordisk a/s (NVO.US) up over 2%.
White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
We're Not Very Worried About Structure Therapeutics' (NASDAQ:GPCR) Cash Burn Rate
No Data
No Data
I Am 102927471 :